{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T08:27:30Z","timestamp":1794731250134,"version":"4.9.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,29]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Obesity and diabetes of different types are considered global health risks with rising prevalence. In addition to low-calorie diet and daily exercise, several treatment options have been introduced to help patient in needs. Semaglutide (Ozempic) is one popular agent, which attracted the attention of both physicians and patients due to its positive outcome in improving glucose control and weight loss. However, no reports on the effect of semaglutide use on the oral cavity and specifically xerostomia are available in the literature. We are reporting 3 cases for patients who were using semaglutide and developed secondary xerostomia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>Three female patients with median age of 34 (range 27\u201346) presented to the oral medicine clinic with chief complaint of xerostomia. All patients were overweight with a mean body mass index of 35.6 (range 35\u201337) and have been using semaglutide for weight loss for a mean duration of 11.3 weeks (range 6\u201316).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>All 3 patients had severe dryness in the mouth with minimal frothy saliva with mean modified Schirmer test of 9\u2009mL at 3 minutes (range 8\u201310\u2009mL). Following exclusion of other possible underlying medical problems, the diagnosis of semaglutide-induced hyposalivation was given to all patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patients\u2019 management varied between discontinuation of the drug, the use of pilocarpine, and conservative symptomatic management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patients resumed acceptable salivary flow.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We are reporting for the first time hyposalivation associated with the use of semaglutide. Further prospective, larger studies are warranted to confirm these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036730","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:09:32Z","timestamp":1704816572000},"page":"e36730","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Semaglutide-associated hyposalivation: A report of case series"],"prefix":"10.1097","volume":"102","author":[{"given":"Hani Haytham","family":"Mawardi","sequence":"first","affiliation":[{"name":"Department of Oral and Diagnostic Sciences, King Abdul-Aziz University \u2013 Faculty of Dentistry, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6350-3578","authenticated-orcid":false,"given":"Soulafa Adnan","family":"Almazrooa","sequence":"additional","affiliation":[{"name":"Department of Oral and Diagnostic Sciences, King Abdul-Aziz University \u2013 Faculty of Dentistry, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraj Ahmed","family":"Dakhil","sequence":"additional","affiliation":[{"name":"Department of Endodontics, King Abdul-Aziz University \u2013 Faculty of Dentistry, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Anwar","family":"Aboalola","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery and Diagnostic Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"Dental Services, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer Abdulmohsin","family":"Al-Ghalib","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics, Batterjee Dental College, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawah Talal","family":"Eshky","sequence":"additional","affiliation":[{"name":"Department of Preventive Dental Sciences, Taibah University \u2013 College of Dentistry, Medina, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham Abdulmajeed","family":"Niyazi","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics, Batterjee Dental College, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Haytham","family":"Mawardi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14863","article-title":"Semaglutide for the treatment of overweight and obesity: a review.","volume":"25","author":"Bergmann","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/CRD.0000000000000430","article-title":"Semaglutide for weight loss: was it worth the weight?","volume":"30","author":"Novograd","year":"2022","journal-title":"Cardiol Rev"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/87551225221137493","article-title":"Evaluating weight loss with semaglutide in elderly patients with type II diabetes.","volume":"39","author":"Huynh","year":"2023","journal-title":"J Pharm Technol"},{"key":"R4-20250503","first-page":"90","article-title":"Semaglutide (Wegovy) for the treatment of obesity.","volume":"107","author":"Bald","year":"2023","journal-title":"Am Fam Physician"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"786732","DOI":"10.3389\/fendo.2021.786732","article-title":"Corrigendum: safety of semaglutide.","volume":"12","author":"Smits","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.archoralbio.2014.05.008","article-title":"Modified schirmer test\u2014a screening tool for xerostomia among subjects on antidepressants.","volume":"59","author":"Kumar","year":"2014","journal-title":"Arch Oral Biol"},{"key":"R7-20250503","first-page":"45","article-title":"Diagnosis and management of xerostomia and hyposalivation.","volume":"11","author":"Villa","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"199","DOI":"10.17219\/acem\/29375","article-title":"Xerostomia of various etiologies: a review of the literature.","volume":"25","author":"Tanasiewicz","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.kint.2022.12.028","article-title":"Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.","volume":"103","author":"Tuttle","year":"2023","journal-title":"Kidney Int"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dom.14890","article-title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.","volume":"25","author":"Kosiborod","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.36290\/vnl.2022.018","article-title":"Oral semaglutide - Rybelsus(R), the first GLP-1 receptor agonist for oral use in clinical practice.","volume":"68","author":"Karasek","year":"2022","journal-title":"Vnitr Lek"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s13300-020-00798-x","article-title":"The effect of glucagon-like peptide-1 receptor agonists on renal outcomes in type 2 diabetes.","volume":"11","author":"Yin","year":"2020","journal-title":"Diabetes Ther"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1127417","DOI":"10.3389\/fimmu.2023.1127417","article-title":"Pathogenesis and treatment of Sjogren\u2019s syndrome: review and update.","volume":"14","author":"Zhan","year":"2023","journal-title":"Front Immunol"},{"key":"R15-20250503","first-page":"e29518","article-title":"Overview of methotrexate toxicity: a comprehensive literature review.","volume":"14","author":"Hamed","year":"2022","journal-title":"Cureus"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jdi.13764","article-title":"Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: a subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials.","volume":"13","author":"Yabe","year":"2022","journal-title":"J Diabetes Investig"},{"key":"R17-20250503","first-page":"372","article-title":"Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2 The SEVERAL study.","volume":"46","author":"Seijas-Amigo","year":"2022","journal-title":"Farm Hosp"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:24:58Z","timestamp":1746318298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":16,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036730","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}